alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# L_2018017EN.01000901.xml

| 23.1.2018 | EN | Official Journal of the European Union | L 17/9 |
| --- | --- | --- | --- |

23.1.2018

EN

Official Journal of the European Union

L 17/9

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/95

of 9 January 2018

entering a name in the register of protected designations of origin and protected geographical indications [‘Slavonski med’ (PDO)]

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1151/2012 of the European Parliament and of the Council of 21 November 2012 on quality schemes for agricultural products and foodstuffs (1), and in particular Article 52(2) thereof,

Whereas:

| (1) | Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, Croatia's application to register the name ‘Slavonski med’ was published in the Official Journal of the European Union (2). |
| --- | --- |

(1)

Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, Croatia's application to register the name ‘Slavonski med’ was published in the Official Journal of the European Union (2).

| (2) | As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Slavonski med’ should therefore be entered in the register, |
| --- | --- |

(2)

As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Slavonski med’ should therefore be entered in the register,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Slavonski med’ (PDO) is hereby entered in the register.

The name specified in the first paragraph denotes a product in Class 1.4. – Other products of animal origin (eggs, honey, various dairy products except butter, etc.), as listed in Annex XI to Commission Implementing Regulation (EU) No 668/2014 (3).

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 9 January 2018.

For the Commission,

On behalf of the President,

Phil HOGAN

Member of the Commission

---

(1)  
  OJ L 343, 14.12.2012, p. 1.

1

(2)  
  OJ C 292, 2.9.2017, p. 7.

2

(3)  Commission Implementing Regulation (EU) No 668/2014 of 13 June 2014 laying down rules for the application of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs (OJ L 179, 19.6.2014, p. 36).

3

---
2

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    

     

    
      
         

      

      
        12
# L_2008206EN.01003402.xml

| 2.8.2008 | EN | Official Journal of the European Union | L 206/34 |
| --- | --- | --- | --- |

2.8.2008

EN

Official Journal of the European Union

L 206/34

---

Corrigendum to Council Directive 94/28/EC of 23 June 1994 laying down the principles relating to the zootechnical and genealogical conditions applicable to imports from third countries of animals, their semen, ova and embryos, and amending Directive 77/504/EEC on pure-bred breeding animals of the bovine species

(
  Official Journal of the European Union L 178 of 12 July 1994
  )

On page 67, in Article 3(2)(c):

for:

| ‘c) | be surprised by an official inspection service of the third country,’, |
| --- | --- |

‘c)

be surprised by an official inspection service of the third country,’,

read:

| ‘(c) | be supervised by an official inspection service of the third country,’; |
| --- | --- |

‘(c)

be supervised by an official inspection service of the third country,’;

on page 67, in Articles 2(1), 3(1), 3(2) in the introductory sentence, 3(2)(b), 3(2)(d), 4 in the first indent, Article 5 in the first indent, and

on page 68 in Articles 6 in the first indent and 7 in the first indent;

for:

‘authority’ and ‘authorities’,

read:

‘body’ and ‘bodies’.

---
Benefits Trust Agreement



 Exhibit 10.4 
 Amended Schedule 2.1 to the Directors’ Deferred Compensation and Benefits Trust Agreement 
 Schedule 2.1
to the Directors’ Deferred Compensation and Benefits  
 Trust Agreement Benefit Plans and Other Arrangements Subject to
Trust 
 (1) Sunoco, Inc. Directors’ Deferred Compensation Plan I; 
 (2) Sunoco, Inc. Directors’ Deferred Compensation Plan II; 
 (3) The entire funding for all the Indemnification Agreements with the directors set forth below shall be Five Million Dollars ($5,000,000.00) in the aggregate upon a Potential Change in Control, and an amount upon a
Change in Control calculated on the basis of the Indemnification Agreements with the following directors: 
  

			
	(a)	  	Robert J. Darnall
	(b)	  	Ursula O. Fairbairn
	(c)	  	Thomas P. Gerrity
	(d)	  	Rosemarie B. Greco
	(e)	  	James G. Kaiser
	(f)	  	R. Anderson Pew
	(g)	  	G. Jackson Ratcliffe
	(h)	  	John W. Rowe
	(i)	  	John K. Wulff

 (4) Benefits payable to former directors of the Company (or their beneficiaries) in pay status as
of the date of termination of the Sunoco, Inc. Non-Employee Directors’ Retirement Plan.
# EUR-Lex - 31990Y0104(02) - EN

Avis juridique important

*|*

# 31990Y0104(02)

**Information from the Commission - List of spirituous beverages in Annex II to Council Regulation (EEC) No 1576/89 the minimum alcoholic strength of which as determined by national laws is higher than the values laid down in the Community Regulations for the category to which they belong **

*
Official Journal C 001 , 04/01/1990 P. 0014 - 0017 *

List of spirituous beverages in Annex II to Council Regulation (EEC) No 1576/89 (1) the minimum alcoholic strength of which as determined by national laws is higher than the values laid down in the Community regulations for the category to which they belong (Article 3 (2) of Regulation (EEC) No 1576/89) (90/C 1/07)

FRANCE > TABLE POSITION>

GERMANY >TABLE>

ITALY >TABLE>

LUXEMBOURG >TABLE>
# m8914.docx

EUROPEAN COMMISSION Brussels, 30.05.2018 C(2018) 3561 final To the notifying party Subject : Case M. 8914 - ONE EQUITY PARTNERS / WALKI HOLDING Commission decision pursuant to Article 6(1 )( b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 27 April 2018 , the European Commission received notification of a proposed conc entration pursuant to Article 4 of the Merger Regulation by which the undertaking One Equity Partners VII, L . P . (‘OEP’, Cayman Islands ), through its wholly ‐owned subsidiary OEP FiberPack Cayman Co Ltd , acquire s within the meaning of Article 3(1 )( b) of the Merger Regulation sole control of the whole of the undertaking Walki Holding Oy (‘ Walki ’, Finland ) by way of purchase of shares . 3 2. The business activities of the undertakings concerned are: - for OEP: private equity funds, - for Walki : technical laminates and protective packaging materials. 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(b ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1 )( b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission
( S igned)
Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 167 , 15 . 5 . 2018 , p. 19 .
(4)
OJ C 366, 14.12.2013, p. 5 .
#### § 1143.11 Does not apply to foreign distribution.

The provisions of this part do not apply to a manufacturer or distributor of tobacco products that does not manufacture, package, or import tobacco products for sale or distribution within the United States.
79–008

106TH CONGRESS REPORT " ! HOUSE OF REPRESENTATIVES 2d Session 106–767

PROVIDING FOR THE CONSIDERATION OF H.R. 4871, THE

TREASURY AND GENERAL GOVERNMENT APPROPRIATIONS ACT, 2001

JULY 19, 2000.—Referred to the House Calendar and ordered to be printed

Mr. LINDER, from the Committee on Rules,

submitted the following

REPORT

[To accompany H. Res. 560]

The Committee on Rules, having had under consideration House

Resolution 560, by a nonrecord vote, report the same to the House

with the recommendation that the resolution be adopted.

SUMMARY OF PROVISIONS OF THE RESOLUTION

The resolution provides for the consideration of H.R. 4871, the

Treasury and General Government Appropriations Act, 2001, under

an open rule. The rule provides one hour of general debate divided

equally between the chairman and ranking minority member of the

Committee on Appropriations.

The rule waives all points of order against consideration of the

bill. The rule further waives clause 2 of rule XXI (prohibiting unauthorized appropriation, legislative provisions or re-appropriations

in a general appropriations bill) against provisions in the bill, except as otherwise specified in the rule.

Members who have preprinted their amendments in the Congressional Record prior to their consideration will be given priority in

recognition to offer their amendments if otherwise consistent with

House rules. The Chairman of the Committee of the Whole may

postpone votes during consideration of the bill, and reduce voting

time to five minutes on a postponed question if the vote follows a

fifteen minute vote. Finally, the rule provides for one motion to recommit, with or without instructions.

The waiver of all points of order against consideration of the bill

includes a waiver of clause 4 of rule XIII (requiring a three-day layover of the committee report) because the report was not filed until

Tuesday, July 18, and the bill may be considered on the floor as

early as Thursday, July 20. The waiver of clause 2 of rule XXI is

2

necessary because there are several unauthorized and legislative

provisions in the bill, which are listed in the report accompanying

H.R. 4871 (H. Rept. 106–756), as well as several transfers of funds.

The description of provisions relating to the transfers of funds and

descriptions of provisions constituting legislation on an appropriation bill and unauthorized provisions can also be found in the report.

Æ
§ 1271.230 Process validation. ( a ) *General.* Where the results of processing described in § 1271.220 cannot be fully verified by subsequent inspection and tests, you must validate and approve the process according to established procedures. The validation activities and results must be documented, including the date and signature of the individual(s) approving the validation.
( b ) *Written representation.* Any written representation that your processing methods reduce the risk of transmission of communicable disease by an HCT/P, including but not limited to, a representation of sterility or pathogen inactivation of an HCT/P, must be based on a fully verified or validated process.
( c ) *Changes.* When changes to a validated process subject to paragraph (a) of this section occur, you must review and evaluate the process and perform revalidation where appropriate. You must document these activities.
Editorial Note on Part 112
Editorial Note: Nomenclature changes to part 112 appear at 81 FR 49896, July 29, 2016.

§ 112.124 What requirements apply to instruments and controls used to measure, regulate, or record? Instruments or controls you use to measure, regulate, or record temperatures, hydrogen-ion concentration (pH), sanitizer efficacy or other conditions, in order to control or prevent the growth of microorganisms of public health significance, must be: ( a ) Accurate and precise as necessary and appropriate in keeping with their purpose;
( b ) Adequately maintained; and
( c ) Adequate in number for their designated uses.
<PAGE>


                                                                   EXHIBIT 23.02


                    CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the incorporation by reference in the Prospectus
constituting part of the Registration Statements on Form S-3 (No. 333-22735,
No. 333-48565 and No. 333-50779) of HNC Software Inc. of our report dated
January 25, 2000, relating to the financial statements of Retek Inc., which
appear in this Form 10-K. We also consent to the incorporation by reference
in the Registration Statements on Form S-8 (No. 33-92902, No. 333-14323, No.
333-18871, No. 333-42819, No. 333-46875, No. 333-50623, No. 333-62195, No.
333-71923, No. 333-80965, No. 333-87953, and No. 333-89165) of HNC Software
Inc. of our report dated January 25, 2000, relating to the financial
statements of Retek Inc., which appear in this Form 10-K.

PRICEWATERHOUSECOOPERS LLP


Minneapolis, Minnesota
March 23, 2000
[Federal Register Volume 75, Number 250 (Thursday, December 30, 2010)]
[Notices]
[Page 82386]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-32976]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[ER-FRL-8994-4]


Environmental Impacts Statements; Notice of Availability

    Responsible Agency: Office of Federal Activities, General 
Information (202) 564-1399 or http://www.epa.gov/compliance/nepa/.

Weekly receipt of Environmental Impact Statements Filed 12/20/2010 
Through 12/23/2010
Pursuant to 40 CFR 1506.9.

Notice

    In accordance with Section 309(a) of the Clean Air Act, EPA is 
required to make its comments on EISs issued by other Federal agencies 
public. Historically, EPA met this mandate by publishing weekly notices 
of availability of EPA comments, which includes a brief summary of 
EPA's comment letters, in the Federal Register. Since February 2008, 
EPA has included its comment letters on EISs on its Web site at: http://www.epa.gov/compliance/nepa/eisdata.html. Including the entire EIS 
comment letters on the website satisfies the Section 309(a) requirement 
to make EPA's comments on EISs available to the public. Accordingly, on 
March 31, 2010, EPA discontinued the publication of the notice of 
availability of EPA comments in the Federal Register.

EIS No. 20100481, Draft EIS, FERC, CA, Eagle Mountain Pumped Storage 
Hydroelectric Project, Licensing Application for Eagle Mountain Mine, 
near the town of Desert Center, Riverside County, CA, Comment Period 
Ends: 02/14/2011, Contact: Kenneth Hogan 202-502-8434.

Amended Notices

EIS No. 20100449, Draft EIS, USFS, MT, Stillwater Mining Revised Water 
Management Plans and BOE Ranch LAD, Implementation, Stillwater and Nye 
Counties, MT, Comment Period Ends: 02/24/2011, Contact: Patrick Pierson 
406-657-6200 Ext. 213.

    Revision to FR Notice Published 11/26/2010: Extending Comment 
Period from 01/10/2011 to 02/24/2011.

    Dated: December 27, 2010.
Ken Mittelholtz,
Deputy Director, NEPA Compliance Division, Office of Federal 
Activities.
[FR Doc. 2010-32976 Filed 12-29-10; 8:45 am]
BILLING CODE 6560-50-P
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 974 Introduced in House (IH)]

109th CONGRESS
  2d Session
H. RES. 974

  Supporting the goals and ideals of National Myositis Awareness Day.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 28, 2006

     Mr. Israel (for himself and Ms. Foxx) submitted the following 
  resolution; which was referred to the Committee on Government Reform

_______________________________________________________________________

                               RESOLUTION

 
  Supporting the goals and ideals of National Myositis Awareness Day.

Whereas an estimated 30,000 to 50,000 people are affected by myositis in the 
        United States, many of whom remain undiagnosed or misdiagnosed;
Whereas myositis is a general term used to describe swelling of the muscles, but 
        the effects of the inflammatory myopathies (often referred to as 
        ``myositis'') are much more severe than just inflammation;
Whereas myositis patients suffer from their immune systems attacking their 
        body's own normal, healthy tissue, resulting in inflammation or 
        swelling;
Whereas inflammatory myopathies are thought to be autoimmune diseases, such that 
        the body's immune system, which normally fights infections and viruses, 
        does not stop fighting once the infection or virus is gone;
Whereas myositis can cause muscle weakness, and patients often live in chronic 
        pain and have long-term health problems that lead to permanent 
        disability;
Whereas myositis is difficult to diagnose and treatment is often delayed, 
        resulting in unnecessary suffering;
Whereas many patients with treatable forms of myositis often have severe long-
        term disabilities because of failure to diagnose and/or treat the 
        disease correctly;
Whereas some myositis patients will die at a much earlier age than they would 
        have if they had received the proper care, particularly for the children 
        who have permanent scarring and deformities due to failure to treat 
        properly;
Whereas The Myositis Association, the national patient advocacy organization 
        serving the myositis patient community, focuses its efforts on public 
        policy, research funding, patient services, and public awareness and 
        education related to developing effective treatments and a cure for 
        myositis;
Whereas a National Myositis Awareness Day would educate communities across the 
        Nation about myositis and the need for research funding, accurate 
        diagnosis, and effective treatments; and
Whereas it would be appropriate to observe September 21, 2006, as National 
        Myositis Awareness Day: Now, therefore, be it
    Resolved,  That the House of Representatives supports the goals and 
ideals of a National Myositis Awareness Day.
                                 <all>
```
EXHIBIT 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of National Medical Health Card Systems, Inc. (the Company) on Form 10-Q for the period ending December 31, 2005
as filed with the Securities and Exchange Commission on the date hereof (the Report), I, James F. Smith, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906
of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



(1)
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|                                                                   
|-------------------------------------------------------------------
|/s/ James F. Smith                                                 
|James F. Smith                                                     
|President and Chief Executive Officer (Principal Executive Officer)
|February 9, 2006
Order filed December 15, 2011.

In The

Fourteenth Court of Appeals

____________

NO. 14-11-00918-CV

____________

CITIBANK, N.A., Appellant

V.

DON M. ESTES, Appellee

On Appeal from County Court No. 3

Galveston County, Texas

Trial Court Cause No. CV-0064944

O R D E R

The notice of appeal in this case was filed October 17, 2011. To date, the filing fee 

of $175.00 has not been paid. No evidence that appellant is excused by statute or the 

Texas Rules of Appellate Procedure from paying costs has been filed. See Tex. R. App. 

P. 5. Therefore, the court issues the following order. 

Appellant is ordered to pay the filing fee in the amount of $175.00 to the Clerk of 

this court on or before December 30, 2011. See Tex. R. App. P. 5. If appellant fails to 

timely pay the filing fee in accordance with this order, the appeal will be dismissed.

PER CURIAM